Henry Schein
Henry Schein, Inc., a leading global provider of healthcare products and services, is headquartered in the United States. Founded in 1932, the company has established a strong presence in the dental, medical, and veterinary sectors, serving healthcare professionals across North America, Europe, and Asia. With a diverse portfolio that includes dental supplies, medical equipment, and practice management software, Henry Schein is renowned for its commitment to innovation and customer service. The company has achieved significant milestones, including its recognition as one of the Fortune 500 and its consistent ranking among the top healthcare distributors globally. Henry Schein's unique approach combines comprehensive product offerings with tailored solutions, making it a trusted partner for healthcare providers seeking to enhance patient care and operational efficiency.
DitchCarbon Score
How does Henry Schein's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Henry Schein's score of 69 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Henry Schein's reported carbon emissions
In 2023, Henry Schein, Inc. reported total carbon emissions of approximately 82481 tonnes CO2e from Scope 1 and Scope 2 combined, with Scope 1 emissions at about 58304 tonnes CO2e and Scope 2 emissions at approximately 24177 tonnes CO2e. The company also disclosed significant Scope 3 emissions, totalling about 776259 tonnes CO2e, which includes categories such as capital goods and business travel. Henry Schein has set ambitious climate commitments, aiming to reduce its Scope 1 emissions by 42% by 2030 from a 2022 baseline, and by 90% by 2050. Additionally, the company has committed to achieving net-zero greenhouse gas emissions across all scopes by 2050. For Scope 3 emissions, Henry Schein targets a reduction of 51.6% per million USD value added by 2030 and 97% by 2050, both from a 2022 baseline. The company is also focused on increasing its sourcing of renewable electricity from 0% in 2022 to 100% by 2030. These targets align with the Science-Based Targets initiative (SBTi) and reflect Henry Schein's commitment to sustainable practices within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 48,846,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Henry Schein is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
